ABVC BioPharma, Inc.
ABVC
$0.911
$0.0354.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.90M | -5.52M | -8.65M | -9.90M | -7.79M |
| Total Depreciation and Amortization | 200.90K | 381.00K | 381.50K | 375.20K | 380.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.30M | 4.05M | 5.66M | 5.61M | 2.73M |
| Change in Net Operating Assets | -408.40K | -665.10K | -675.90K | 752.30K | 490.80K |
| Cash from Operations | -1.81M | -1.75M | -3.28M | -3.16M | -4.19M |
| Capital Expenditure | -- | 0.00 | -21.20K | -21.20K | -21.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 154.20K | 101.60K | -339.00K | -339.00K |
| Cash from Investing | -- | 154.20K | 80.40K | -360.20K | -360.20K |
| Total Debt Issued | 971.70K | 392.20K | -1.43M | -1.46M | 1.46M |
| Total Debt Repaid | -356.10K | -365.60K | -186.50K | -186.50K | -1.19M |
| Issuance of Common Stock | 978.50K | 902.20K | 1.92M | 1.05M | 1.05M |
| Repurchase of Common Stock | -7.30K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 394.10K | 508.90K | 2.94M | 2.94M | 2.54M |
| Cash from Financing | 1.98M | 1.44M | 3.24M | 2.34M | 3.87M |
| Foreign Exchange rate Adjustments | -24.60K | -197.00K | -42.90K | 50.10K | 2.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.00K | -351.10K | 500.00 | -1.13M | -675.00K |